Gyroscope Theraputics secures £50.4m Series B financing
Syncona and Cambridge Innovation Capital will contribute £48 million and £2.4 million, respectively.
Read More
Tag: Series B financing
- Strong clinical data for Breye lead asset danegaptide
- EHP Awards triumph
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
